Literature DB >> 8065322

In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.

T A Shapiro1, A F Showalter.   

Abstract

Kinetoplast DNA, the mitochondrial DNA of trypanosomes, is a topologically complex structure composed of interlocked minicircles and maxicircles. We previously reported that etoposide, a potent inhibitor of topoisomerase II, promotes the cleavage of about 20% of network minicircle DNA (T. A. Shapiro, V. A. Klein, and P. T. Englund, J. Biol. Chem. 264:4173-4178, 1989). We now find that virtually all maxicircles are released from kinetoplast DNA networks after trypanosomes are treated with etoposide. As expected for a topoisomerase II cleavage product, the linearized maxicircles have protein bound to both 5' ends. After etoposide treatment, the residual minicircle catenanes have a sedimentation coefficient which is only 70% that of controls, and by electron microscopy the networks are less compact. Double-size networks, the characteristic dumbbell-shape forms that normally arise in the final stages of network replication, are replaced by aberrant unit-size forms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065322      PMCID: PMC359115          DOI: 10.1128/mcb.14.9.5891-5897.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  The physical properties of the deoxyribonucleic acid from T7 bacteriophage.

Authors:  P F DAVISON; D FREIFELDER
Journal:  J Mol Biol       Date:  1962-12       Impact factor: 5.469

2.  A nicked form of kinetoplast DNA in Leishmania tarentolae.

Authors:  P T Englund; D C DiMaio; S S Price
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

3.  Isolation of the kinetoplast DNA of Leishmania tarentolae in the form of a network.

Authors:  L Simpson; J Berliner
Journal:  J Protozool       Date:  1974-05

4.  Replication of kinetoplast DNA maxicircles.

Authors:  S L Hajduk; V A Klein; P T Englund
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

Review 5.  The molecular biology of trypanosomes.

Authors:  P T Englund; S L Hajduk; J C Marini
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

6.  Isolation and characterization of kinetoplast DNA networks and minicircles from Crithidia fasciculata.

Authors:  A M Simpson; L Simpson
Journal:  J Protozool       Date:  1974-11

7.  The replication of kinetoplast DNA networks in Crithidia fasciculata.

Authors:  P T Englund
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

8.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Complete nucleotide sequence of minicircle kinetoplast DNA from Trypanosoma equiperdum.

Authors:  M Barrois; G Riou; F Galibert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  Isolation and characterization of kinetoplast DNA from bloodstream form of Trypanosoma brucei.

Authors:  A H Fairlamb; P O Weislogel; J H Hoeijmakers; P Borst
Journal:  J Cell Biol       Date:  1978-02       Impact factor: 10.539

View more
  8 in total

Review 1.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

2.  The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.

Authors:  Danielle P Cavalcanti; Stênio P Fragoso; Samuel Goldenberg; Wanderley de Souza; Maria Cristina M Motta
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

3.  Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.

Authors:  A L Bodley; T A Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

4.  Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

Authors:  M Omar F Khan
Journal:  Drug Target Insights       Date:  2007-06-19

5.  Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Rakhee Das; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2005-04-28       Impact factor: 16.971

Review 6.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

Review 7.  Physiological Roles of DNA Double-Strand Breaks.

Authors:  Farhaan A Khan; Syed O Ali
Journal:  J Nucleic Acids       Date:  2017-10-18

Review 8.  The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.

Authors:  Rubem Figueiredo Sadok Menna-Barreto; Solange Lisboa de Castro
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.